Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glabellar Frown Lines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05148000
What this trial is testing

Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines

Who this might be right for
Glabellar Frown LinesCanthal Lines
Galderma R&D 25
Testing effectiveness (Phase 2)Study completedNCT04996810
What this trial is testing

The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Protox Inc. 60
Large-scale testing (Phase 3)Study completedNCT03908008
What this trial is testing

Efficacy and Safety Study of MT10107 in the Treatment of Glabella Line

Who this might be right for
Glabellar Frown Lines
Medy-Tox 136
Large-scale testing (Phase 3)Study completedNCT06946160
What this trial is testing

A Non-inferiority Clinical Trial to Compare Efficacy and Safety of Abobotulinumtoxin A (Espad Pharmed) Versus AbobotulinumtoxinA (Dysport®, Ipsen Co.) for Correction of Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar LinesGlabellar Frown Lines
Espad Pharmed 146
Large-scale testing (Phase 3)UnknownNCT05623410
What this trial is testing

Study to Compare the Efficacy and Safety of ATGC-110 (Botulinum Toxin) With Xeomin® for the Treatment of Moderate to Severe Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
ATGC Co., Ltd. 300
Large-scale testing (Phase 3)Study completedNCT00752050
What this trial is testing

Safety and Efficacy Study of Repeat Treatment With PurTox® Botulinum Toxin Type A for Frown Lines Between the Eyebrows

Who this might be right for
Glabellar RhytidesFrown Lines Between the Eyebrows
Mentor Worldwide, LLC 699
Post-approval studies (Phase 4)Study completedNCT03289169
What this trial is testing

Long-term Safety and Efficacy of MEDITOXIN® in Treatment Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medy-Tox 300
Testing effectiveness (Phase 2)Study completedNCT05320393
What this trial is testing

Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 154
Large-scale testing (Phase 3)Study completedNCT00770029
What this trial is testing

IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2

Who this might be right for
Moderate to Severe Glabellar Frown Lines
Merz Pharmaceuticals GmbH 276
Very early researchUnknownNCT04715048
What this trial is testing

Split-Face Study Comparing Botox and Jeuveau in Treating Glabellar Lines

Who this might be right for
Glabellar Frown Lines
University of Southern California 20
Very early researchUnknownNCT05083286
What this trial is testing

Duration of Botox Using OLD Versus COLD for Treatment of Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Clinical Testing of Beverly Hills 40
Large-scale testing (Phase 3)Study completedNCT03014622
What this trial is testing

Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Revance Therapeutics, Inc. 303
Testing effectiveness (Phase 2)Study completedNCT00430586
What this trial is testing

Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
Merz Pharmaceuticals GmbH 191
Not applicableStudy completedNCT01391299
What this trial is testing

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines

Who this might be right for
Facial RhytidesGlabellar Frown Lines
Allergan 175
Post-approval studies (Phase 4)UnknownNCT01583478
What this trial is testing

Comparison of Escalating Doses of IncobotulinumtoxinA (Xeomin®) in the Treatment of Glabellar Rhytids

Who this might be right for
Skin AgingElastosis Senilis
The Maas Clinic 15
Large-scale testing (Phase 3)Study completedNCT05146999
What this trial is testing

Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Galderma R&D 132
Large-scale testing (Phase 3)Study completedNCT00512135
What this trial is testing

Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines

Who this might be right for
Glabellar Lines
Merz Pharmaceuticals GmbH 801
Large-scale testing (Phase 3)Study completedNCT01189760
What this trial is testing

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines

Who this might be right for
Facial RhytidesCrow's Feet LinesGlabellar Lines
Allergan 917
Not applicableEnded earlyNCT05222607
What this trial is testing

Longitudinal Evaluation and Real-world Evidence of NT201

Who this might be right for
Glabellar Frown Lines and Canthal Lines and/or Horizontal Forehead Lines in the Upper Face
Merz North America, Inc. 11
Post-approval studies (Phase 4)Looking for participantsNCT06448676
What this trial is testing

Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides

Who this might be right for
WrinkleGlabellar Frown LinesGlabellar Furrowing
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 325
Next Page